Skip to Main content Skip to Navigation
Master Thesis

La mélatonine dans la prise en charge des troubles du sommeil des enfants atteints de troubles du spectre de l’autisme

Abstract : According to INSERM, 1 out of 3 people in France is suffering from sleeping disorder. The booming of melatonin-based treatments lead me to educate people coming to the pharmacy for advice on this ‘sleep hormone’. Through a literature review, I investigated sleep architecture, its associated pathologies and the use of melatonin to heal them. I mapped the therapeutic treatments based on melatonin available on the French market and ran a comparative analysis to highlight their specificities. SLENYTO® was recently authorized and put on the market for the treatment of Autism Spectrum Disorder (ASD) among children. Treating sleeping disorder among them is indeed a step in caring for them. Finally, this thesis lead to the production of two advice sheets: one for patients and their families, the other for chemists, in order to promote the good use of this new treatment.
Document type :
Master Thesis
Complete list of metadata

https://dumas.ccsd.cnrs.fr/dumas-03377363
Contributor : Odonto Ub - Connect in order to contact the contributor
Submitted on : Thursday, October 14, 2021 - 10:32:45 AM
Last modification on : Wednesday, November 24, 2021 - 3:16:18 AM

File

Pharmacie_2021_Girard.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-03377363, version 1

Collections

Citation

Amélie Girard. La mélatonine dans la prise en charge des troubles du sommeil des enfants atteints de troubles du spectre de l’autisme. Sciences du Vivant [q-bio]. 2021. ⟨dumas-03377363⟩

Share

Metrics

Record views

5